The University of Arizona
Map Home
Loading...
Adjust height of sidebar
KMap

Grant

Multicenter, Open-label, Phase 2 Study of Carboplatin Plus Mirvetuximab Soravtansine Followed by Mirvetuximab Soravtansine Continuation in Folate

Sponsored by ImmunoGen Incorporated

Active
$419.4K Funding
3 People
External

Related Topics

People